This is a $10,744.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product "EBGLYSS 250 MG/2 ML PEN 2ML" and has a performance period ending on July 10, 2025. This award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.76, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, EBGLYSS 250 MG/2 ML PEN 2ML, with a firm fixed price of $1,819.44 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product, with a ceiling value of $2,760.70 and a completion date of July 3, 2025. The contract is firm fixed price and non-set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML, a medical product, with a firm fixed price of $7,369.62 and a completion date of May 13, 2025. The contract is not set aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,954.68 firm-fixed-price delivery order covers the supply of EBGLYSS 250 MG/2 ML PEN 2ML medical products, with a period of performance through January 28, 2025. There is no set-aside designation on this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at $2,725.21, is for 4567614301 !...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,080.31, is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $959,878.28 contract is for the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is part of Amerisourcebergen's larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,960.79 contract is for the provision of various pharmaceutical products and medical supplies, including medications across multiple therapeutic categories such as diabetes, neurology, pain management, and antibiotics. The contract has no set-aside designation, indicating open competition. This delivery order is part of a larger...